ImmuCell Corporation

NASDAQ: ICCC · Real-Time Price · USD
6.09
-0.63 (-9.38%)
At close: Aug 15, 2025, 3:59 PM
6.19
1.64%
After-hours: Aug 15, 2025, 04:10 PM EDT

ImmuCell Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.76M 978.74K 5.79M 10.19M
Short-Term Investments
n/a n/a n/a -468
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
33.37K 57.66K 76.63K 26.11K
Receivables
3.81M 2.19M 1.8M 2.72M
Inventory
7.11M 7.81M 6.04M 3.09M
Other Current Assets
n/a 39.73K n/a n/a
Total Current Assets
15.04M 11.47M 13.99M 16.26M
Property-Plant & Equipment
29.91M 32.15M 30.64M 28M
Goodwill & Intangibles
114.66K 133.76K 152.87K 171.97K
Total Long-Term Assets
30.06M 32.34M 30.87M 28.2M
Total Assets
45.1M 43.81M 44.86M 44.47M
Account Payables
n/a 874.56K 790K 745.04K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.5M 1.43M 1.04M 812.21K
Other Current Liabilities
337.37K 306.78K n/a n/a
Total Current Liabilities
4.41M 4.2M 3.07M 2.53M
Long-Term Debt
9.04M 10.54M 9.19M 8.33M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
13.17M 14.62M 11.41M 9.35M
Total Liabilities
17.58M 18.82M 14.48M 11.89M
Total Debt
15.1M 16.69M 12.48M 10.27M
Common Stock
904.24K 781.42K 781.42K 781.42K
Retained Earnings
-14.16M -12.01M -6.23M -3.74M
Comprehensive Income
n/a -0.00 -0.00 -0.00
Shareholders Equity
27.52M 24.99M 30.38M 32.58M
Total Investments
n/a n/a n/a -468